NABP Informs EU Stakeholders About .Pharmacy as a Tool to Combat Counterfeit Drugs Globally
December 22, 2016
NABP representatives traveled to Brussels, Belgium, in mid-November 2016 to meet with regulators and stakeholders as part of the Association’s continued efforts to raise awareness of the .Pharmacy Top-Level Domain Program and its role in combating counterfeit drugs. NABP met with representatives of the European Healthcare Distribution Association, the Pharmaceutical Group of the European Union, and the US trade mission to the EU. NABP and EU regulators also discussed the EU member states’ implementation of the common logo, a mandatory, hyperlinked seal of approval demonstrating the validity of licensed internet pharmacies operating in the EU, and how the .pharmacy initiative might support and complement this program.